A critical breakthrough in cancer study is arising with the use of mini-antibodies to restore mutated p53. This vital cancer protector protein is frequently inactivated in several types of cancer, resulting https://bookmarkassist.com/story21828317/nanobodies-reactivate-tumor-suppressor-p53-a-promising-pathway-for-malignant-management